A detailed history of Smartleaf Asset Management LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Smartleaf Asset Management LLC holds 232 shares of BBIO stock, worth $6,134. This represents 0.0% of its overall portfolio holdings.

Number of Shares
232
Previous 53 337.74%
Holding current value
$6,134
Previous $1.34 Million 333.41%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$23.91 - $31.3 $4,279 - $5,602
179 Added 337.74%
232 $5.79 Million
Q2 2024

Aug 13, 2024

BUY
$23.0 - $31.04 $1,219 - $1,645
53 New
53 $1.34 Million

Others Institutions Holding BBIO

About BridgeBio Pharma, Inc.


  • Ticker BBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 148,246,000
  • Market Cap $3.92B
  • Description
  • BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...
More about BBIO
Track This Portfolio

Track Smartleaf Asset Management LLC Portfolio

Follow Smartleaf Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smartleaf Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Smartleaf Asset Management LLC with notifications on news.